Ilyang to operate flu vaccine plant

Published: 2011-03-16 06:56:00

Updated: 2011-03-16 06:56:00

Ilyang Pharmaceutical Co. says it will complete its vaccine plant for influenza with an annual egg-based production capacity of 60 million doses of flu vaccine in Jecheon, North Chungcheong on April 11, one year after its ground-breaking.

“In an effort to secure an adequate supply of the vacci...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK